Cargando…
Enhancement of anticancer efficacy using modified lipophilic nanoparticle drug encapsulation
BACKGROUND: Development of anticancer drugs is challenging. Indeed, much research effort has been spent in the development of new drugs to improve clinical outcomes with minimal toxicity. We have previously reported that a formulation of lipid gold porphyrin nanoparticles reduced systemic drug toxic...
Autores principales: | Lee, Puiyan, Zhang, Ruizhong, Li, Vincent, Liu, Xuelai, Sun, Raymond WY, Che, Chi-Ming, Wong, Kenneth KY |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3282612/ https://www.ncbi.nlm.nih.gov/pubmed/22359452 http://dx.doi.org/10.2147/IJN.S28783 |
Ejemplares similares
-
Polymer–lipid hybrid nanoparticles as potential lipophilic anticancer drug carriers
por: Salel, Sedef, et al.
Publicado: (2023) -
Development and Study of Nanoemulsions and Nanoemulsion-Based Hydrogels for the Encapsulation of Lipophilic Compounds
por: Demisli, Sotiria, et al.
Publicado: (2020) -
Development of a Novel Lipophilic, Magnetic Nanoparticle for in Vivo Drug Delivery
por: Linemann, Thomas, et al.
Publicado: (2013) -
On the encapsulation and assembly of anticancer drugs in a cooperative fashion
por: Wang, Weikun, et al.
Publicado: (2019) -
Study of Lipophilicity and ADME Properties of 1,9-Diazaphenothiazines with Anticancer Action
por: Morak-Młodawska, Beata, et al.
Publicado: (2023)